The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019

Amendment of regulation 75 (obligation to provide information relating to safety etc)

This section has no associated Explanatory Memorandum

83.  In regulation 75(5)(1)—

(a)for sub-paragraph (a) substitute—

(a)in a country other than the United Kingdom; and

(b)in sub-paragraph (b), insert “UK” before “marketing authorisation”.

(1)

Regulation 75 was amended by S.I. 2014/1878.